Never miss a great news story!
Get instant notifications from Economic Times
AllowNot now


You can switch off notifications anytime using browser settings.

Portfolio

Loading...
Select Portfolio and Asset Combination for Display on Market Band
Select Portfolio
Select Asset Class
Show More
Download ET MARKETS APP

Get ET Markets in your own language

DOWNLOAD THE APP NOW

+91

CHOOSE LANGUAGE

ENG

  • ENG - English
  • HIN - हिन्दी
  • GUJ - ગુજરાતી
  • MAR - मराठी
  • BEN - বাংলা
  • KAN - ಕನ್ನಡ
  • ORI - ଓଡିଆ
  • TEL - తెలుగు
  • TAM - தமிழ்
Drag according to your convenience
ET NOW RADIO
ET NOW
TIMES NOW
Prefer niche pharma cos to those in generic space: Devang Mehta, Centrum Wealth

We have stayed underweight on Sun Pharma, Lupin and Dr Reddy’s, says Mehta

We are sitting on the sidelines, not much churn is happening now: Chakri Lokapriya

There is no point selling because valuations look okay now, says Lokapriya.

During fiscal expansion, cutting rates aggressively will be adding fuel to fire: Krishna Memani, Oppenheimer Funds

"Corporate governance and leverage have been perennial issues in Indian corporate sector"

Market not pricing in earnings recovery for a few quarters: Jonathan Schiessl

"Emerging market space will continue to attract capital flow as against developed markets."

Corporate facing banks would top growth chart: Anand Tandon

If you are looking at value investing, certainly the index is not the place to be.

10,500-10,600 a strong support zone for Nifty: Kunal Bothra

REC and PFC have been doing extremely well even in a market which has become very volatile.

Find verified Mutual Funds Consultants near your location

BULL'S EYE

Only technicals matter; terrorist attack, upcoming elections are passing phases: Vivek Mavani

A huge amount of leverage built during the 2013-2018 bull market, is now unravelling, says Mavani.

Broader markets have seen 50%, 60% corrections which is a sign of bear market:  Nitin Raheja

We are going to see a liquidity pressure as far as the markets are concerned, says Raheja.

In FY20,expecting 16-18% earnings growth for Nifty: Shibani Sircar Kurian, Kotak Mahindra AMC

Premiumisation as a theme is playing out in consumer stocks, says Kurian.

Dr Reddy’s heading for big trouble: Amit Rajan, Celogen Life Sciences

There are multiple problems ahead of Dr Reddy’s in coming days, says Rajan.

We are always looking at opportunities to enhance shareholder value: Amritanshu Khaitan, Eveready

We are always looking at opportunities to enhance shareholder value: Amritanshu Khaitan, Eveready

As we scale up, the margins in lighting should improve substantially, says Khaitan.

New product launches will continue to drive growth: Glenn Saldanha, Glenmark

New product launches will continue to drive growth: Glenn Saldanha, Glenmark

Our EBITDA margins continue to be about 17 plus per cent, says Glenmark Pharma CMD

Huge money waiting on sidelines for India, waiting for clarity on politics & liquidity: Madhav Dhar, GTI Capital

Huge money waiting on sidelines for India, waiting for clarity on politics & liquidity: Madhav Dhar, GTI Capital

Money will come in as growth accelerates. India is still very much on people’s radar, says Dhar.

This pessimism is overdone; I have not seen such despondency in broader market in many years: Sanjiv Bhasin

This pessimism is overdone; I have not seen such despondency in broader market in many years: Sanjiv Bhasin

Six months onwards, you will be making a lot of money in select stocks, says Bhasin

Investors are okay about taking a valuation risk  but not earnings or governance risk: H Nemkumar, IIFL

Investors are okay about taking a valuation risk but not earnings or governance risk: H Nemkumar, IIFL

Market sentiment is downbeat, fresh capital allocations unlikely before election, says Nemkumar.

Jet deal not clear about where cash to run operation will come from: Dhiraj Mathur, PwC

Jet deal not clear about where cash to run operation will come from: Dhiraj Mathur, PwC

Converting debt into equity does not bring in any money into the company, says Mathur.

Load More...
1
BACK TO TOP